NCT06909981

Brief Summary

The main goal of this pilot study is to understand the impact of a mobile lung cancer screening clinics in individuals from neighborhoods and communities with less access to resources in Boston, Massachusetts who are at high risk for lung cancer. A secondary goal of this pilot study is to understand how social determinants of health impact these neighborhoods and communities. Another secondary goal of this pilot study is to see if video recording of participants speaking to their future selves and sending the videos back to participants to encourage them to get lung cancer screening after one year can be administered in a mobile lung cancer screening setting. The questions this study aims to answer are:

  • Is mobile lung cancer screening is feasible and acceptable?
  • Is collecting social needs data during the mobile lung cancer screening clinics feasible?
  • Is creating video recordings of patients encouraging their future selves to get lung cancer screening after one year feasible? Participants will:
  • Complete an intake survey, providing information about their demographic, medical, and social needs information.
  • Undergo a shared decision-making conversation to determine whether lung cancer screening should be done.
  • Undergo lung cancer screening.
  • Undergo a debriefing conversation and fill out an acceptability survey.
  • Record a video speaking to their future selves about the importance of annual lung cancer screening, with the video to be sent back to them after roughly one year.
  • Undergo a semi-structured phone interview between four and eight weeks after lung cancer screening date.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
125

participants targeted

Target at P50-P75 for not_applicable

Timeline
6mo left

Started May 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress4%
May 2026Nov 2026

First Submitted

Initial submission to the registry

March 21, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 4, 2025

Completed
1.1 years until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

December 8, 2025

Status Verified

December 1, 2025

Enrollment Period

6 months

First QC Date

March 21, 2025

Last Update Submit

December 2, 2025

Conditions

Keywords

Lung Cancer Screening

Outcome Measures

Primary Outcomes (2)

  • Feasibility of mobile lung cancer screening in target communities in Boston, Massachusetts.

    This outcome will be assessed by calculating the raw count of individuals screened at each mobile clinic and the number of individuals unable to be screened due to time constraints.

    During the intervention.

  • Acceptability of mobile lung cancer screening in target communities in Boston, Massachusetts.

    Acceptability will be assessed using semi-structured phone interviews with participants. Responses to questions, themes, and keywords will be analyzed to report attitudes regarding the intervention.

    Between four and eight weeks after the intervention

Secondary Outcomes (2)

  • Feasibility of collecting social determinants of health data during mobile lung cancer screening clinics in underserved communities in Boston, Massachusetts.

    Pre-intervention

  • Feasibility of administering a video-based intervention to encourage annual lung cancer screening

    From enrollment until the end of the study.

Study Arms (1)

Lung Cancer Screening

EXPERIMENTAL

Participants will complete a baseline questionnaire and undergo a shared decision-making with the study team to determine whether they will receive lung cancer screening. If the participant and team member determine that lung cancer screening should be performed, they will undergo screening. Regardless of whether lung cancer screening is performed, participants will undergo a debriefing conversation. An acceptability survey will be given to participants who underwent lung cancer screening. Those who undergo lung cancer screening will also be video-recorded speaking to their future selves as encouragement to get annual lung cancer screening. Imaging results will be returned to the participant and their care team within two weeks after lung cancer screening. Semi-structured interviews will also be performed with participants who underwent lung cancer screening between four and eight weeks after lung cancer screening. Video footage will be returned to patients after 48 weeks.

Radiation: Low-Dose Computed Tomography Scan

Interventions

Imaging of chest to screen for lung cancer.

Also known as: CT Scan, LDCT Scan, CAT Scan
Lung Cancer Screening

Eligibility Criteria

Age50 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ability to understand and the willingness to sign a written informed consent document prior to any study-related procedures.
  • Willing to undergo treatment.
  • Adults between the ages of 50 and 80 years.
  • No recent CT imaging within the last year.
  • Currently smokes tobacco or has quit smoking tobacco within the past 15 years.
  • Has a tobacco smoking history of at least 20 pack years (i.e. one pack per day for the last 20 years or equivalent).
  • Has never been diagnosed with lung cancer.

You may not qualify if:

  • Adults/children less than 50 years, or greater than 80 years of age.
  • Has never smoked tobacco.
  • Has smoked tobacco but quit more than 15 years ago.
  • Has a tobacco smoking history of less than 20 pack years.
  • Presence of major comorbidity(ies) that could prevent treatment.
  • Previous diagnosis of lung cancer.
  • In the opinion of the investigator, the subject is not an appropriate candidate for the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Surgeon, Vice Chair for Workforce Development & Engagement

Study Record Dates

First Submitted

March 21, 2025

First Posted

April 4, 2025

Study Start

May 1, 2026

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

December 8, 2025

Record last verified: 2025-12